CONSOLIDATION THERAPY USING 90Y‐IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012). (12th June 2019) - Kanno, M.; Miura, K.; Masaki, Y.; Tsujimura, H.; Iino, M.; Takizawa, J.; Maeda, Y.; Yamamoto, K.; Tamura, S.; Yoshida, A.; Yagi, H.; Yoshida, I.; et al.